Drugs Made In America Acquisition Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DMAAU | ABTC | APUS | ANIP | AMRX | ACXP | |
|---|---|---|---|---|---|---|
| Market cap | — | 575.28M | 4.76M | 1.70B | 7.12B | 6.42M |
| P/E (TTM) | — | — | — | 16.0 | 41.7 | — |
| Forward P/E | — | 8.9 | — | 7.3 | 17.0 | -0.7 |
| Price/book | -36.3 | 0.9 | 4.9 | 2.6 | 198.5 | 0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +6.31% | −88.59% | −81.26% | −23.88% | +93.86% | −82.31% |
| Today | 0.00% | −8.56% | −2.90% | +2.18% | +1.24% | +0.43% |
The closest companies by business and industry (Shell Companies). Prices may be delayed up to 15 min.
Latest news
All DMAAU news ›Price to earnings forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU
TradingView Drugs Made In America Acquisition Corp. Price to earnings forward of Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition II Corp. News — NASDAQ:DMII
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.